News - 31 May 2013 09:00

PSMF establishment and maintenance, business as usual?

Since the implementation of Directive 2010/84 and Regulation 1235/2010, marketing authorisation holders (MAHs) with products on the European market are obliged to maintain, and make available upon request, a Pharmacovigilance System Master File (PSMF).

The PSMF comprises a range of annexes supported by a main document that, in its entirety, encapsulates the respective MAHs approach to continuous monitoring of a given product’s risk-benefit balance.

But how do companies ensure that the PSMF and corresponding annexes are updated and successfully reflect the company’s pharmacovigilance system? And how do you as an organisation successfully implement and maintain a PSMF without the need for additional resources?

Topics

Data, Telecom, IT

Contacts

Tina Joanne Hindsbo

Press contact Head of Public & Media Relations tnjh@nnit.com +45 3077 9578

Sofie Mand Steffens

Press contact Senior Communications Consultant smst@nnit.com +45 3077 8337

Related media

PSMF establishment and maintenance, business as usual?

PSMF establishment and maintenance, business as usual?
License: Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format: .pdf

Make the most of serialization

Change is afoot for pharmaceutical companies, with new serialisation legislation on the agenda. To help stem the problem of drug counterfeiting, they will be required to adopt a unique serial number labelling system and adapt their business processes accordingly. How can companies derive real business value from the investments they are now required to make?

12 April 2013 09:00

BI tool for smooth submission planning and execution

Regulatory approval for pharmaceutical products can be difficult to obtain, not least because the submission process is often slow and prone to errors. Thomas Svendsen and Peter Noes of NNIT tell World Pharmaceutical Frontiers how regulatory teams can use a business intelligence tool to monitor submission status and hasten time to market.

19 June 2013 09:00

ISO IDMP is the next after xEVMPD

ISO IDMP is the next wave in the pharmacovigilance legislation after xEVMPD. But with a global scope and requiring data integration from the entire company it is a much bigger wave. ISO IDMP will transform your regulatory IT strategy.

1 July 2013 10:00

Global Tracking Regulations Present Challenges and Benefits

Drug makers are facing an ever-increasing challenge as more countries implement serialization and tracking regulations and set compliance deadlines in an effort to ensure the safety and quality of prescription drugs being sold within their borders. Complying with regulations coming into effect will be a demanding task due to a lack of global harmonization.

15 August 2013 09:00

NNIT is ready with SAP's new integration platform

The latest version of the integration tool SAP PO is a pure Java solution that runs faster and provides new opportunities for communication with EDI systems. The new version of SAP Process Orchestration is both smarter and faster than its predecessor. Companies must consider a number of aspects before deciding on an upgrade, advises SAP expert Peter Kreiner from NNIT.

21 January 2014 08:00

Are you ready for ISO IDMP?

Following the implementation of XEVMPD, new legislation, based on five new ISO IDMP standards, is due to come into force in 2016. Rune Ringsholm Bergendorff, advanced business consultant at NNIT, explains how pharmaceutical companies will need to adapt business processes across the whole organisation.